RVPH   $2.65  -5.69% Market Closed After Close 2.6012 -1.84%

Reviva Pharmaceuticals Holdings, Inc.
Total Cash 6.18M
totalCashPerShare 0.207
EBITDA
Total Debt 207.50K
quickRatio 0.443
currentRatio 0.519
Total Revenue
debtToEquity
Revenue/Share
ROA -2.33951
ROE
grossProfits
freeCashflow -17.42M
operatingCashflow -35.26M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 21.33M
forwardPE -1.1518519
floatShares 26.65M
sharesOutstanding 33.44M
sharesShort 5.31M
sharesShortPriorMonth 5.80M
dateShortInterest
sharesPercentSharesOut 0.16%
heldPercentInsiders 0.15%
heldPercentInstitutions 0.21%
Short Ratio help_outline 21.49%
shortPercentOfFloat 0.19%
impliedSharesOutstanding
bookValue -0.203
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -35.99M
trailingEps -1.32%
forwardEps -0.81%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.25 3Q 2024
institutionsCount 37
lastUpdated Nov. 7, 2024, 3:31 a.m.